- Trials with a EudraCT protocol (325)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
325 result(s) found for: Cardiac monitoring.
Displaying page 1 of 17.
EudraCT Number: 2015-004485-28 | Sponsor Protocol Number: 38RC15.214 | Start Date*: 2016-01-18 | |||||||||||
Sponsor Name:Centre Hospitalier Universitaire de Grenoble | |||||||||||||
Full Title: | |||||||||||||
Medical condition: Patients should be operated for cardiac surgery with cardiac bypass and in sinus rhythm, and for which the fact of the existence of impaired left ventricular function or the heaviness of the surgic... | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004150-27 | Sponsor Protocol Number: KAR0001HEARTCAT | Start Date*: 2005-11-03 |
Sponsor Name:Universitätsklinik für Kinder- und Jugendheilkunde | ||
Full Title: RANDOMIZED CONTROLLED TRIAL COMPARING TWO HEPARINIZATION PROTOCOLS FOR PROPHYLAXIS OF SHORT- AND LONG-TERM THROMBOTIC COMPLICATIONS OF PEDIATRIC CARDIAC CATHETERIZATION The HEARTCAT – Study (HEpar... | ||
Medical condition: Patients requiring diagnostic or interventional cardiac catheterisation (without Stent, device or catheter ablation) | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-016364-36 | Sponsor Protocol Number: P09 | Start Date*: 2010-07-06 | |||||||||||
Sponsor Name: | |||||||||||||
Full Title: Injection of Autologous Bone Marrow Cells into Damaged Myocardium of No-option Patients with Ischemic Heart Failure: a randomized placebo controlled trail. | |||||||||||||
Medical condition: Ischemic heart failure is associated with significant morbidity and mortality. The number of patients with severe heart failure that remains symptomatic despite optimal pharmacological and non-phar... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022579-68 | Sponsor Protocol Number: COR-1/02 | Start Date*: 2011-08-16 | |||||||||||
Sponsor Name:Corimmun GmbH | |||||||||||||
Full Title: COR-1, an anti-ß1 receptor antibody cyclopeptide in heart failure: a phase II, multicentre, randomised, double-blind and placebo-controlled study with parallel groups | |||||||||||||
Medical condition: Heart Failure, Dilated Cardiomyopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019464-37 | Sponsor Protocol Number: 2010-019464-37 | Start Date*: 2011-04-14 | |||||||||||
Sponsor Name:FONDAZIONE TOSCANA GABRIELE MONASTERIO | |||||||||||||
Full Title: effects of dynamic co2 therapy in periodic breathing in heart failure patients | |||||||||||||
Medical condition: Patients hospitalized for heart failure and central sleep apnea syndrome in the Cardiovascular Medicine Department, Fondazione G. Monasterio, Pisa | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-000561-28 | Sponsor Protocol Number: SOSP- CLOP | Start Date*: 2008-05-08 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA` GRANDA (A.O. DI RILIEVO NAZIONALE) | ||||||||||||||||||
Full Title: Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of bridging antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. | ||||||||||||||||||
Medical condition: prevention of cardiac ischemic events in patients undergoing major or ocular surgery | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-022679-71 | Sponsor Protocol Number: Xenon-MTH-Studie | Start Date*: 2011-01-07 | |||||||||||
Sponsor Name:Clinical Trials Center Aachen, University of Aachen | |||||||||||||
Full Title: Xenon and Therapeutical Hypothermia After Successful Cardiopulmonary Resuscitation | |||||||||||||
Medical condition: In this clinical trial will be checked, whether 2 hours ventilation with xenon has neuroprotetctive effect on the patients, which had out of hospital cardiac arrest and successful cardiopulmonary r... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000263-92 | Sponsor Protocol Number: 17-251 | Start Date*: 2018-05-28 | |||||||||||
Sponsor Name:CHU CAEN | |||||||||||||
Full Title: Spironolactone and perioperative atrial fibrillation occurrence in cardiac surgery patients: a multicenter randomized, double-blind study | |||||||||||||
Medical condition: Patients > 18 years referred for elective cardiac bypass graft (CABG) surgery ± aortic valve replacement (AVR) without any systolic heart failure or any mitral surgery associated | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000537-69 | Sponsor Protocol Number: PROP2% | Start Date*: 2015-09-21 |
Sponsor Name:Universitair Ziekenhuis Brussel | ||
Full Title: Real time monitoring of blood propofol concentration | ||
Medical condition: - General anaesthesia - Pharmacokinetics and Pharmacodynamics of Propofol - Inflammatory parameters - Elective thyroid, oncologic breast,ENT or cervical arthrodesis surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-012850-19 | Sponsor Protocol Number: PCR/CLL/09 | Start Date*: 2009-06-03 | ||||||||||||||||
Sponsor Name:AZIENDA SANITARIA LOCALE DI BARI | ||||||||||||||||||
Full Title: Statins IN TREATMENT OF ACUTE coronary syndrome. COMPARISON OF EFFICACY BETWEEN Atorvastatin and Rosuvastatin IN PATIENTS UNDERGO A PTCA THROUGH THE MONITORING OF C REACTIVE PROTEIN | ||||||||||||||||||
Medical condition: Patients with Acute coronary syndrome without up-leveling of ST line. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003012-21 | Sponsor Protocol Number: AI-700-34 | Start Date*: 2006-12-28 | |||||||||||
Sponsor Name:Acusphere, Inc. | |||||||||||||
Full Title: A Phase 3, International, Exploratory, Open-Label, Multicenter, Dual-Injection, Echocardiographic Imaging Settings and Safety Study of AI-700 in Normal Volunteers and Stable Cardiac Patients (Acqui... | |||||||||||||
Medical condition: AI-700 is an intravenous (IV) ultrasound contrast agent designed for echocardiographic imaging for myocardial defect detection. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001518-13 | Sponsor Protocol Number: 10407 | Start Date*: 2018-11-12 |
Sponsor Name:Maatschap Cardiologie Zwolle | ||
Full Title: Comparison between treatment with catheter ablation or anti-arrhythmic drugs (sotalol or combination of verapamil and flecainide) of patients with benign ventricular premature beats and ventricular... | ||
Medical condition: Premature ventricular beats, ventricular ectopy, ventricle tachycardia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2021-005876-21 | Sponsor Protocol Number: DANOHCA-001 | Start Date*: 2022-07-08 | |||||||||||
Sponsor Name:Department of Cardiology, Copenhagen University Hospital, Rigshospitalet | |||||||||||||
Full Title: The Danish Out-of-Hospital Cardiac Arrest study (DANOHCA) | |||||||||||||
Medical condition: We will investigate the efficacy of four interventions (two pharmaceutical) for reducing mortality and organ damage in patients resuscitated after out-of-hospital cardiac arrest. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020376-37 | Sponsor Protocol Number: CP120027.2001 | Start Date*: 2011-02-11 | |||||||||||||||||||||||||||||||
Sponsor Name:Trevena, Inc. | |||||||||||||||||||||||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Adaptive, Ascending Dose-Titration Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Invasive Hemodynamics of TRV120027 in Patient... | |||||||||||||||||||||||||||||||||
Medical condition: Heart failure | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005920-16 | Sponsor Protocol Number: CHUB-930105 | Start Date*: 2012-02-06 |
Sponsor Name:Association Hospitalière CHU Brugmann | ||
Full Title: Prospective, controled, randomized, double blind monocentric study evaluating the efficacy of the basic component of colloids (corn versus potato) on perioperative blood losses in elective cardiac ... | ||
Medical condition: Elective cardiac surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-002752-20 | Sponsor Protocol Number: LAN_POAF_01 | Start Date*: 2020-12-17 | |||||||||||
Sponsor Name:Medical University of Vienna | |||||||||||||
Full Title: A prospective, randomized, double- blind, placebo- controlled study to evaluate the efficacy of Landiolol hydrochloride for prevention of atrial fibrillation in patients undergoing cardiac surgery | |||||||||||||
Medical condition: Perioperative atrial fibrillation (POAF) is the most common arryhthmia after cardiac surgery with incidences ranging from 20% to 40%, depending on various patient's risk factors and the type of sur... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001923-22 | Sponsor Protocol Number: ADENOSINE-1 | Start Date*: 2015-12-16 |
Sponsor Name:Amphia Ziekenhuis | ||
Full Title: The effect of adenosine on myocardial protection in intermittent warm blood cardioplegia: a randomized placebo-controlled trial | ||
Medical condition: Post-operative cardiac damage in patients scheduled for minimal invasive, port-access operations | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002556-27 | Sponsor Protocol Number: ALBICS | Start Date*: 2016-11-25 | |||||||||||
Sponsor Name:Helsinki University Hospital | |||||||||||||
Full Title: Albumin in cardiac surgery | |||||||||||||
Medical condition: Cardiac surgery with cardiopulmonary bypass operations. Elective and emergency patients. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005685-30 | Sponsor Protocol Number: 2015-005685-30 | Start Date*: 2016-04-08 |
Sponsor Name:Hôpital Erasme | ||
Full Title: Evaluation of microcirculation alterations in cardiac surgery, by FMD (Flow Mediated vasoDilation), Near Infrared Spectrophotometry (NIRS) and biological analysis | ||
Medical condition: Cardiac pathology eligible for surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2010-018767-42 | Sponsor Protocol Number: CEUS-TEVAR-29 | Start Date*: 2011-05-06 | |||||||||||
Sponsor Name:FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR | |||||||||||||
Full Title: The use of Contrast Enhanced Transesophageal Echocardiography in thoracic endovascular aortic repair (TEVAR). Feasibility and safety of a new tool for intraoperative monitoring and follow up. | |||||||||||||
Medical condition: descending thoracic aorta diseases | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
